Drug distribution is a technique for giving medicinal substances (drugs) to people and animals in order to have a therapeutic impact. Technology utilised to regulate the pace of medication release is referred to as advanced drug delivery systems (ADDS). These technologies offer more effective ways to deliver the medication molecule to the desired location. Modern drug delivery systems provide patients with practical choices, such as quick and simple drug administration, precise dosage administration, and increased patient adherence. However, the technology employed will vary depending on the ailment, medicine, and desired outcome.
By the end of 2022, the market for innovative drug delivery systems is anticipated to be worth US$ 231,816.3 Mn.
Request a Sample Copy of the Research Report :
During the projected period, the market for advanced drug delivery systems is anticipated to rise as sophisticated drug delivery systems are being used across the globe. The use of cutting-edge medicine delivery methods is growing quickly along with the occurrence of diseases. The first generic version of Symbicort, an inhalation aerosol used to treat asthma in individuals 6 years of age and older and chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and/or emphysema, received FDA approval in March 2022.
Globally increasing rates of chronic illnesses like cancer are predicted to create sizable growth prospects for companies in the advanced drug delivery systems industry. For instance, a variety of pharmacotherapies utilised in numerous applications, such as the treatment of cancer, are transported via sophisticated drug delivery systems. Thus, the adoption of cutting-edge medication delivery methods is growing along with the occurrence of cancer. The World Health Organization (WHO) reports that cancer was the biggest cause of death globally in 2020, accounting for close to 10 million deaths, or close to one in every six.
The market for enhanced medication delivery systems is predicted to expand slowly due to issues with drug delivery and product recalls. INOMAX DS drug-delivery systems in the United States are being voluntarily recalled in August 2020 as a result of a potential pressure switch failure that might affect how patients receive INOMAX (nitric oxide) for inhalation. According to what I remember, this course is being offered with permission from the US Food and Drug Administration (FDA).
The market for innovative medicine delivery systems has been significantly affected by the COVID-19 epidemic. Numerous studies stressed the role that cutting-edge drug delivery systems would play in improving the therapeutic medicines already on the market. For instance, AstraZeneca, Chalmers University of Technology, and the University of Gothenburg in Sweden announced new crucial research integrating several intriguing concepts to look into a nasal spray mRNA vaccine against COVID-19 in June 2020.
Request a Sample Copy of the Research Report :
The market for advanced drug delivery systems was valued at US$ 221,410.0 Mn in 2021 and is anticipated to grow at a CAGR of 5.0% from 2022 to 2028 to reach US$ 311,542.2 Mn. In terms of type, the oral drug delivery system segment dominated the worldwide advanced drug delivery systems market in 2022, holding a 38.1% value share. Increasing product approval and launches are anticipated to fuel sector expansion throughout the course of the forecast period.
The number of clinical studies will likely rise, which will help the market for sophisticated drug delivery systems develop. For instance, Progenity Inc. published encouraging preliminary preclinical findings in 2020 on the performance of its capsule-based oral drug delivery system, which employs a unique autonomous localization technique to locate the ileal/ileocecal area of the GI (Gastrointestinal) tract.
The global market for innovative drug delivery systems is anticipated to increase as a result of frequent approvals and launches of new products. For instance, the Center for Drug Evaluation and Research (CDER) of the U.S. Food and Drug Administration (FDA) estimates that in 2020, about 53 novel molecular entities were authorised.
Purchase This Complete Business Research Report:
Note: Special discounted pricing is only applicable for direct purchase through website. In case of customization, discount would be subject to scope and coverage of the report.
Bayer Healthcare, Amgen Inc., Baxter International, Glaxosmithkline, Abbott Laboratories, Celgene Corporation, 3M Company, Boston Scientific, Astellas Pharma, and Astrazeneca, are a few of the major companies active in the worldwide market for advanced drug delivery systems.
The FDA granted Corium, Inc.’s ADLARITY (donepezil transdermal system) approval in March 2022 as a therapy for individuals with mild, moderate, or severe Alzheimer’s-related dementia.
Under the trade name Molshil, Shilpa Medicare Ltd. introduced an oral thin film formulation in June 2021 that contains a paediatric dosage of paracetamol. The first of its type in the world, Shilpa’s paracetamol oral thin films are patented and protected. Shilpa has also been given the go-ahead for its oral thin film formulation of Molshil after satisfactorily meeting the criteria for bioequivalence.
Explore Detail TOC of the Advanced Drug Delivery Systems Market Report:
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Advanced Drug Delivery Systems Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Advanced Drug Delivery Systems Industry Impact
Chapter 2 Global Advanced Drug Delivery Systems Competition by Types, Applications, and Top Regions and Countries
2.1 Global Advanced Drug Delivery Systems (Volume and Value) by Type
2.3 Global Advanced Drug Delivery Systems (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Advanced Drug Delivery Systems Sales, Consumption, Export, Import by Regions
Chapter 5 North America Advanced Drug Delivery Systems Market Analysis
Chapter 6 East Asia Advanced Drug Delivery Systems Market Analysis
Chapter 7 Europe Advanced Drug Delivery Systems Market Analysis
Chapter 8 South Asia Advanced Drug Delivery Systems Market Analysis
Chapter 9 Southeast Asia Advanced Drug Delivery Systems Market Analysis
Chapter 10 Middle East Advanced Drug Delivery Systems Market Analysis
Chapter 11 Africa Advanced Drug Delivery Systems Market Analysis
Chapter 12 Oceania Advanced Drug Delivery Systems Market Analysis
Chapter 13 South America Advanced Drug Delivery Systems Market Analysis
Chapter 14 Company Profiles and Key Figures in Advanced Drug Delivery Systems Business
Chapter 15 Global Advanced Drug Delivery Systems Market Forecast (2022-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027